Dr. Pisick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2520 Elisha Ave
Zion, IL 60099Phone+1 800-322-9183Fax+1 847-731-1017
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2006
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2000 - 2003
- Boston University School of MedicineClass of 2000
Certifications & Licensure
- MI State Medical License 2021 - 2027
- IL State Medical License 2006 - 2026
- OH State Medical License 2022 - 2026
- OK State Medical License 2023 - 2026
- IA State Medical License 2021 - 2025
- IN State Medical License 2022 - 2025
- WI State Medical License 2023 - 2025
- Join now to see all
Publications & Presentations
PubMed
- Palbociclib in Patients With Head and Neck Cancer and Other Tumors WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Francis P Worden, Evan Pisick, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer
JCO Precision Oncology. 2024-10-01 - 1 citationsLeveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.Sravani Ramisetty, Ayalur Raghu Subbalakshmi, Siddhika Pareek, Tamara Mirzapoiazova, Dana Do
Journal of Clinical Medicine. 2024-06-05 - 2 citationsRegorafenib in Patients With Solid Tumors WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Vaibhav Sahai, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vijay Suhag
JCO Precision Oncology. 2024-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: